Regeneration Rate Constants and Effective Doubling Times for CD4+ and CD8+ T Cells After Intensive Chemotherapy
Patient No. . | Age . | CD4 g . | CD8 g . | CD4 Td† . | CD8 Td† . |
---|---|---|---|---|---|
. | (yrs) . | (day−1)* . | (day−1)* . | (days) . | (days) . |
1 | 1 | 0.077 | 0.130 | 9 | 5 |
2 | 3 | 0.035 | 0.038 | 20 | 18 |
3 | 7 | 0.055 | 0.072 | 12 | 10 |
4 | 8 | NA | NA | NA | NA |
5 | 11 | 0.008‡ | 0.075‡ | 83 | 9 |
6 | 13 | 0.084 | 0.070 | 8 | 10 |
7 | 13 | NA | NA | NA | NA |
8 | 14 | 0.026 | 0.050 | 28 | 14 |
9 | 18 | 0.021‡ | 0.091‡ | 33 | 8 |
10 | 19 | 0.035 | 0.037 | 20 | 19 |
11 | 19 | 0.003‡ | 0.003‡ | 230 | 230 |
12 | 21 | 0.010 | 0.010 | 69 | 69 |
13 | 23 | 0.030 | 0.060 | 23 | 11 |
14 | 24 | 0 | 0.010 | ∞ | 69 |
15 | 24 | 0.024‡ | 0.530‡ | 29 | 1 |
16 | 24 | 0.003 | 0.011 | 230 | 63 |
Patient No. . | Age . | CD4 g . | CD8 g . | CD4 Td† . | CD8 Td† . |
---|---|---|---|---|---|
. | (yrs) . | (day−1)* . | (day−1)* . | (days) . | (days) . |
1 | 1 | 0.077 | 0.130 | 9 | 5 |
2 | 3 | 0.035 | 0.038 | 20 | 18 |
3 | 7 | 0.055 | 0.072 | 12 | 10 |
4 | 8 | NA | NA | NA | NA |
5 | 11 | 0.008‡ | 0.075‡ | 83 | 9 |
6 | 13 | 0.084 | 0.070 | 8 | 10 |
7 | 13 | NA | NA | NA | NA |
8 | 14 | 0.026 | 0.050 | 28 | 14 |
9 | 18 | 0.021‡ | 0.091‡ | 33 | 8 |
10 | 19 | 0.035 | 0.037 | 20 | 19 |
11 | 19 | 0.003‡ | 0.003‡ | 230 | 230 |
12 | 21 | 0.010 | 0.010 | 69 | 69 |
13 | 23 | 0.030 | 0.060 | 23 | 11 |
14 | 24 | 0 | 0.010 | ∞ | 69 |
15 | 24 | 0.024‡ | 0.530‡ | 29 | 1 |
16 | 24 | 0.003 | 0.011 | 230 | 63 |
The growth rate constant (g) was calculated from the equation dT/dt = gT(1-iT) where T is the number of T cells, t = time, g = growth rate constant and i = inhibitory (regulatory) constant.
Effective cell doubling time was calculated by 0.69/g or 0.69/g* as described in Materials and Methods.
The linear growth rate constant (g*) was calculated by dividing the slopes of the linear time dependences by the initial number of cells (g* = s/a) as described in Materials and Methods.